5.3 Pulmonary Function Testing & Peak Flow Measurement

5.3 Pulmonary Function Testing & Peak Flow Measurement

Pulmonary function testing (PFT) comprises diagnostic and monitoring procedures that evaluate lung mechanics, respiratory volumes, and airflow dynamics. Medical assistants in primary care, pulmonology, allergy, and occupational medicine frequently perform diagnostic spirometry and instruct patients on peak expiratory flow monitoring. Ensuring meticulous pre-test patient preparation, strict adherence to American Thoracic Society (ATS) quality standards, and accurate patient education regarding Asthma Action Plans are critical clinical competencies.

---

1. Principles & Indications of Diagnostic Spirometry

Spirometry is the most common non-invasive pulmonary function test performed in outpatient clinical practice. It measures the volume of air an individual can forcefully inhale and exhale as a function of time.

+---------------------------------------------------------------------------------------+
|                               CLINICAL INDICATIONS FOR SPIROMETRY                     |
|                                                                                       |
|  1. Diagnostic Evaluation: Investigate unexplained dyspnea, chronic cough, wheezing   |
|  2. Disease Differentiation: Differentiate Obstructive (Asthma, COPD) vs Restrictive  |
|  3. Therapeutic Monitoring: Assess bronchodilator responsiveness & drug efficacy      |
|  4. Preoperative Risk Assessment: Evaluate cardiopulmonary risk prior to major surgery|
|  5. Occupational Screening: Screen for occupational dust/chemical exposures (OSHA)   |
|  6. Disability Evaluation: Quantify respiratory impairment for legal/disability claims|
+---------------------------------------------------------------------------------------+

Clinical Contraindications to Spirometric Testing

Because forced spirometric maneuvers generate extreme intrathoracic, intra-abdominal, and intraocular pressures, testing is strictly contraindicated in patients with:

• Recent myocardial infarction or unstable angina (<1 month)
• Recent thoracic, abdominal, or vascular surgery (<4-6 weeks)
• Recent ophthalmic/cataract surgery (risk of increased intraocular pressure and wound dehiscence)
• Known thoracic or abdominal aortic aneurysm
• Recent pneumothorax (<2-4 weeks)
• Active hemoptysis of unknown etiology
• Acute pulmonary embolism
• Severe uncontrolled systemic hypertension (systolic >180 mmHg or diastolic >110 mmHg)

---

2. Pre-Test Patient Preparation & Medication Withholding Protocols

Pre-test compliance is essential to establish accurate, unskewed baseline pulmonary measurements:

General Patient Preparation Instructions

• Smoking & Vaping: Refrain from smoking or vaping tobacco/cannabis for at least 1 hour prior to testing.
• Heavy Meals: Avoid consuming large, heavy meals for at least 2 hours before testing (prevents stomach distension that impedes full diaphragmatic excursion).
• Physical Exertion: Avoid vigorous physical exercise for at least 30 minutes before testing.
• Alcohol Consumption: Avoid intoxicating alcohol for at least 4 hours prior to testing.
• Clothing: Wear loose, non-restrictive clothing around the neck, chest, and abdomen.

Pharmacological Withholding Guidelines

When spirometry is ordered to evaluate baseline pulmonary disease and test for bronchodilator reversibility, respiratory medications must be withheld per provider orders:

+---------------------------------------------------------------------------------------+
|                     BRONCHODILATOR PRE-TEST WITHHOLDING TIMELINE                      |
|                                                                                       |
|  - Short-Acting Beta-2 Agonists (SABA) (Albuterol, Levalbuterol)  --> Hold 4 to 6 hrs |
|  - Short-Acting Muscarinic Antagonists (SAMA) (Ipratropium)       --> Hold 6 to 8 hrs |
|  - Long-Acting Beta-2 Agonists (LABA) (Salmeterol, Formoterol)    --> Hold 12-24 hrs  |
|  - Long-Acting Muscarinic Antagonists (LAMA) (Tiotropium)         --> Hold 24 to 48 hrs|
|  - Inhaled Corticosteroid / LABA Combinations (Advair, Symbicort) --> Hold 24 to 36 hrs|
|  - Oral Theophylline Formulations                                 --> Hold 12-24 hrs  |
+---------------------------------------------------------------------------------------+

---

3. Spirometric Procedure & Technical Execution

Equipment Calibration & Quality Control

• Daily Calibration Verification: The spirometer must be calibrated daily before testing using a certified 3-Liter Calibration Syringe.
• Acceptable Calibration Limits: The measured volume must be within ±3% of 3.00 L (2.91 L to 3.09 L). If the device falls outside these limits, clean, inspect, and recalibrate before testing patients.

Patient Setup & Anthropometric Documentation

• Demographic Inputs: Accurately record the patient's biological sex, age, race/ethnicity, and standing height and weight. Predicted normal values are calculated based on these parameters.
• Height Measurement: Measure standing height without shoes using a stadiometer. Clinical Rule: Height is the single most critical predictor of expected lung volumes. If a patient has severe kyphoscoliosis or cannot stand, measure arm span (fingertip to fingertip with arms outstretched horizontally; Height ~ Arm span / 1.06).
• Patient Posture: Seat the patient upright in a sturdy chair with armrests, back supported, and feet flat on the floor. (Seated posture prevents fall injuries should the patient experience syncope or lightheadedness from forced exhalation).

Step-by-Step Testing Maneuver

1. Apply Nose Clip: Place a padded nose clip securely over the patient's nares to ensure 100% of inhaled and exhaled air travels through the mouth into the spirometer sensor.
2. Tidal Breathing: Instruct the patient to place the single-use disposable mouthpiece in their mouth over the tongue, creating a tight, airtight seal with their lips (avoid blocking the opening with the tongue or biting down).
3. Maximal Inhalation: Have the patient inhale completely, rapidly, and deeply to Total Lung Capacity (TLC).
4. Explosive Exhalation ("The Blast"): Immediately upon reaching full inspiration, coach the patient to blast the air out with maximal force and speed without hesitation.
5. Active Coaching & Duration: The medical assistant must actively coach with enthusiasm: "Blast it out! Blow, blow, blow, keep pushing! Don't stop! Keep going, empty your lungs!" The patient must continue exhaling forcefully for a minimum of 6 seconds in adults (minimum 3 seconds in children <10 years) until a clear expiratory plateau is achieved (no change in volume for >= 1 second).

---

4. ATS Acceptability & Repeatability Criteria

The American Thoracic Society (ATS) and European Respiratory Society (ERS) establish strict quality control standards for diagnostic spirometry:

+-----------------------------------------------------------------------------------------+
|                         ATS SPIROMETRY QUALITY CRITERIA                                 |
|                                                                                         |
|  ACCEPTABILITY CRITERIA (Each Individual Effort):                                       |
|    1. Rapid, explosive start with back-extrapolated volume < 5% of FVC or < 0.100 L     |
|    2. No coughing, glottic closure, or hesitation during the first second of expiration|
|    3. Minimum exhalation duration of >= 6 seconds in adults (>= 3s in children < 10)    |
|    4. Volume-time curve shows a plateau (no volume change >= 1 second)                  |
|    5. Airtight seal with lips; no leak or obstruction by tongue/teeth                   |
|                                                                                         |
|  REPEATABILITY CRITERIA (Across the Session):                                           |
|    - Achieve at least 3 acceptable maneuvers                                            |
|    - The 2 highest FVC values must be within 150 mL (0.150 L) of each other            |
|    - The 2 highest FEV1 values must be within 150 mL (0.150 L) of each other           |
|    - Maximum attempts: Limit to 8 maneuvers per session to prevent patient exhaustion   |
+-----------------------------------------------------------------------------------------+

---

5. Diagnostic Spirometry Parameters & Pattern Differentiation

+---------------------------------------------------------------------------------------+
|                                 KEY SPIROMETRIC PARAMETERS                            |
|                                                                                       |
|  1. Forced Vital Capacity (FVC):                                                      |
|     - Total volume of air exhaled forcefully and rapidly after maximal inhalation     |
|     - Normal: >= 80% of predicted                                                     |
|                                                                                       |
|  2. Forced Expiratory Volume in 1 Second (FEV1):                                      |
|     - Volume of air forcefully exhaled during the first second of the FVC maneuver    |
|     - Normal: >= 80% of predicted; reflects airway resistance and caliber             |
|                                                                                       |
|  3. FEV1 / FVC Ratio (Tiffeneau Index):                                               |
|     - Fraction of total vital capacity exhaled in the initial first second            |
|     - Normal: 70% to 80% (0.70 to 0.80); Primary criterion for Obstructive Disease   |
+---------------------------------------------------------------------------------------+

Obstructive vs. Restrictive Ventilatory Patterns

1. Obstructive Ventilatory Defect:
   • Primary Hallmark: FEV1/FVC Ratio < 70% (<0.70).
   • Mechanism: Airway narrowing and increased resistance to airflow (air trapping).
   • Parameters: Markedly decreased FEV1 (<80% of predicted); FVC is normal or mildly reduced; flow-volume loop exhibits a scooped-out (concave) expiratory limb.
   • Common Pathologies: Asthma, Chronic Obstructive Pulmonary Disease (COPD) (Chronic Bronchitis and Emphysema), Bronchiectasis, and Cystic Fibrosis.
2. Restrictive Ventilatory Defect:
   • Primary Hallmark: FEV1/FVC Ratio >= 70% (Normal or Elevated) with FVC < 80% of predicted.
   • Mechanism: Reduced total lung volume and expansion capacity due to parenchymal stiffness, pleural disease, or chest wall deformity.
   • Parameters: Proportionate reduction in both FVC and FEV1; flow-volume loop maintains normal contour but appears shrunken/narrowed.
   • Common Pathologies: Idiopathic Pulmonary Fibrosis (IPF), Sarcoidosis, Asbestosis, Kyphoscoliosis, Morbid Obesity, ALS, and Myasthenia Gravis.

Bronchodilator Reversibility Testing

• Following baseline spirometry, the patient is administered 4 puffs of a short-acting beta-2 agonist (Albuterol 400 µg) via a metered-dose inhaler (MDI) with a spacer.
• Wait 10 to 15 minutes and repeat spirometry.
• Positive Reversibility Criterion: An increase in FEV1 or FVC of >= 12% AND at least 200 mL (0.200 L) from the pre-bronchodilator baseline.
• Clinical Significance: Confirms reversible airway obstruction characteristic of Asthma, whereas COPD typically exhibits fixed, irreversible or partially reversible obstruction.

---

6. Peak Expiratory Flow (PEF) & Peak Flow Meter Mechanics

Peak Expiratory Flow (PEF) is the maximum speed of exhalation (flow rate) achieved during a short, explosive exhalation initiated from Total Lung Capacity. It is measured in Liters per minute (L/min).

Clinical Role: Monitoring vs. Diagnostic

• A Peak Flow Meter is a simple, handheld, mechanical device designed for daily home self-monitoring by asthma patients.
• It detects early airway narrowing and bronchospasm before the patient perceives physical symptoms (wheezing, dyspnea), providing an objective trigger for preemptive medication adjustment.
• Critical Distinction: Peak flow meters are used for day-to-day monitoring; they cannot diagnose pulmonary diseases or replace diagnostic spirometry.

Establishing the "Personal Best"

To establish a baseline, the patient records peak flow twice daily (upon waking and in late afternoon) for 2 to 3 weeks when their asthma is under optimal clinical control. The highest reading achieved during this 2- to 3-week period is documented as the patient's Personal Best, against which all future daily readings are compared.

Step-by-Step Peak Flow Meter Technique

1. Ensure the sliding indicator/pointer is slid to the very bottom of the scale (zero).
2. Instruct the patient to stand upright (or sit fully erect).
3. Take a deep, maximal inhalation to fill the lungs completely.
4. Place the mouthpiece in the mouth between the teeth; close the lips firmly to form an airtight seal around the opening (do not block the opening with the tongue).
5. Blow out as hard and fast as possible in a single, short, explosive blast (1 second), as if blowing out birthday candles.
6. Read and note the numbered position where the sliding indicator stopped.
7. Reset the indicator to zero; rest for 30 seconds; repeat the maneuver for a total of 3 acceptable trials.
8. Documentation Rule: Record the SINGLE HIGHEST READING of the 3 trials in the asthma diary (never average the values).

---

7. The Asthma Action Plan & Peak Flow Zones

The Asthma Action Plan is a written, individualized management strategy created by the healthcare provider. It divides peak expiratory flow readings into three color-coded zones analogous to a traffic signal:

+-----------------------------------------------------------------------------------------+
|                             ASTHMA ACTION PLAN TRAFFIC ZONES                            |
|                                                                                         |
|  [GREEN ZONE]  --> 80% to 100% of Personal Best  --> SAFETY / WELL-CONTROLLED           |
|  [YELLOW ZONE] --> 50% to 79% of Personal Best   --> CAUTION / ACUTE FLARE / RESCUE SABA|
|  [RED ZONE]    --> < 50% of Personal Best        --> MEDICAL EMERGENCY / CALL 911       |
+-----------------------------------------------------------------------------------------+

Zone Details & Action Thresholds

1. Green Zone (80% to 100% of Personal Best — Safety / Good Control):
   • Symptoms: Breathing is easy; no coughing, wheezing, or chest tightness; sleeping through the night; normal activity and exercise.
   • Action: Continue regular daily long-term maintenance medications (e.g., inhaled corticosteroids, LABA). Take pre-exercise bronchodilator if prescribed.
2. Yellow Zone (50% to 79% of Personal Best — Caution / Acute Flare):
   • Symptoms: Coughing, mild wheezing, chest tightness, shortness of breath, waking at night with asthma, or symptoms during normal physical activities.
   • Action: Airway is narrowing. Immediately administer the prescribed quick-relief rescue bronchodilator (Short-Acting Beta-2 Agonist, e.g., Albuterol 2–4 puffs via spacer). Rest for 20 to 30 minutes and recheck peak flow. If readings remain in the Yellow Zone, increase maintenance medications per the plan and contact the provider.
3. Red Zone (<50% of Personal Best — Medical Emergency):
   • Symptoms: Severe shortness of breath, continuous wheezing or silent chest, talking in 1- to 2-word phrases, intercostal/suprasternal retractions, lips or fingernails turning gray/blue (cyanosis).
   • Action: Severe airway obstruction! Take quick-relief rescue bronchodilator immediately (e.g., Albuterol 4–6 puffs or nebulizer treatment). Take prescribed oral systemic corticosteroid (e.g., Prednisone). Seek emergency medical attention immediately or call 911 without delay.

Asthma Action Plan Peak Flow Zones & Clinical Decision Matrix